Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy

BACKGROUND: Platinum-based chemotherapy remains the essential therapy for small cell lung cancer (SCLC). Here, we conducted a statistical analysis to explore whether the curative efficacy of 2-cycle platinum-based chemotherapy can predict the survival of patients with SCLC. METHODS: Fifty-six SCLC p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kaibo, Jiang, Minlin, Xu, Yi, Chen, Peixin, Wang, Hao, Yu, Jia, Zhu, Jun, Zhao, Wencheng, Meng, Die, He, Yayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947513/
https://www.ncbi.nlm.nih.gov/pubmed/33717593
http://dx.doi.org/10.21037/jtd-21-216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947513/
https://www.ncbi.nlm.nih.gov/pubmed/33717593
http://dx.doi.org/10.21037/jtd-21-216

Ejemplares similares